June 18, 2021
Business News

Alexion Shareholders Approve Acquisition by AstraZeneca

BOSTON–()–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that its shareholders have voted to adopt and approve the previously announced agreement to be acquired by AstraZeneca at a special meeting of shareholders held today.

Ludwig Hantson, Ph.D., Chief Executive Officer, Alexion, said: “We’re very pleased with today’s affirmative shareholder vote, which brings us one step closer to completing a transaction that will accelerate the combined company’s ability to develop and provide access to life-changing medicines for patients with rare and devastating diseases around the world.”

Subject to receipt of additional regulatory clearances, the acquisition is expected to close in the third…

Click here to view the original article.

Related Posts

You might also like ...

Customers Bank Announces Promotions and New Hire in Accounting Department
The Alpha Blue Ocean Family Office is pleased to announce the appointment of Rajae Elantari as Head of PR & Marketing
AON Splash Image
Arkema annonce le lancement d’une nouvelle gamme innovante de grades PVDF d’origine renouvelable pour les batteries lithium-ion